Literature DB >> 16150828

Intestinal cholesterol absorption is substantially reduced in mice deficient in both ABCA1 and ACAT2.

Ryan E Temel1, Richard G Lee, Kathryn L Kelley, Matthew A Davis, Ramesh Shah, Janet K Sawyer, Martha D Wilson, Lawrence L Rudel.   

Abstract

The process of cholesterol absorption has yet to be completely defined at the molecular level. Because of its ability to esterify cholesterol for packaging into nascent chylomicrons, ACAT2 plays an important role in cholesterol absorption. However, it has been found that cholesterol absorption is not completely inhibited in ACAT2-deficient (ACAT2 KO) mice. Because ABCA1 mRNA expression was increased 3-fold in the small intestine of ACAT2 KO mice, we hypothesized that ABCA1-dependent cholesterol efflux sustains cholesterol absorption in the absence of ACAT2. To test this hypothesis, cholesterol absorption was measured in mice deficient in both ABCA1 and ACAT2 (DKO). Compared with wild-type, ABCA1 KO, or ACAT2 KO mice, DKO mice displayed the lowest level of cholesterol absorption. The concentrations of hepatic free and esterified cholesterol and gallbladder bile cholesterol were significantly reduced in DKO compared with wild-type and ABCA1 KO mice, although these measures of hepatic cholesterol metabolism were very similar in DKO and ACAT2 KO mice. We conclude that ABCA1, especially in the absence of ACAT2, can have a significant effect on cholesterol absorption, although ACAT2 has a more substantial role in this process than ABCA1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16150828     DOI: 10.1194/jlr.M500232-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  54 in total

1.  ACAT2 and ABCG5/G8 are both required for efficient cholesterol absorption in mice: evidence from thoracic lymph duct cannulation.

Authors:  Tam M Nguyen; Janet K Sawyer; Kathryn L Kelley; Matthew A Davis; Carol R Kent; Lawrence L Rudel
Journal:  J Lipid Res       Date:  2012-06-05       Impact factor: 5.922

2.  Synthetic LXR agonist suppresses endogenous cholesterol biosynthesis and efficiently lowers plasma cholesterol.

Authors:  Thomas Pfeifer; Marlene Buchebner; Prakash G Chandak; Jay Patankar; Adelheid Kratzer; Sascha Obrowsky; Gerald N Rechberger; Rajendra S Kadam; Uday B Kompella; Gerhard M Kostner; Dagmar Kratky; Sanja Levak-Frank
Journal:  Curr Pharm Biotechnol       Date:  2011-02-01       Impact factor: 2.837

3.  Cellular energy depletion resets whole-body energy by promoting coactivator-mediated dietary fuel absorption.

Authors:  Atul R Chopra; Ramakrishna Kommagani; Pradip Saha; Jean-Francois Louet; Christina Salazar; Junghun Song; Jaewook Jeong; Milton Finegold; Benoit Viollet; Franco DeMayo; Lawrence Chan; David D Moore; Bert W O'Malley
Journal:  Cell Metab       Date:  2011-01-05       Impact factor: 27.287

Review 4.  A new framework for reverse cholesterol transport: non-biliary contributions to reverse cholesterol transport.

Authors:  Ryan-E Temel; J-Mark Brown
Journal:  World J Gastroenterol       Date:  2010-12-21       Impact factor: 5.742

5.  Multiple mechanisms limit the accumulation of unesterified cholesterol in the small intestine of mice deficient in both ACAT2 and ABCA1.

Authors:  Stephen D Turley; Mark A Valasek; Joyce J Repa; John M Dietschy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-08-19       Impact factor: 4.052

6.  Macrophage 12/15 lipoxygenase expression increases plasma and hepatic lipid levels and exacerbates atherosclerosis.

Authors:  Shunxing Rong; Qiang Cao; Mingxia Liu; Jeongmin Seo; Lin Jia; Elena Boudyguina; Abraham K Gebre; Perry L Colvin; Thomas L Smith; Robert C Murphy; Nilamadhab Mishra; John S Parks
Journal:  J Lipid Res       Date:  2012-01-25       Impact factor: 5.922

7.  Opposing Gatekeepers of Apical Sterol Transport: Niemann-Pick C1-Like 1 (NPC1L1) and ATP-Binding Cassette Transporters G5 and G8 (ABCG5/ABCG8).

Authors:  J Mark Brown; Liqing Yu
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2009-03

8.  Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe.

Authors:  Ryan E Temel; Weiqing Tang; Yinyan Ma; Lawrence L Rudel; Mark C Willingham; Yiannis A Ioannou; Joanna P Davies; Lisa-Mari Nilsson; Liqing Yu
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

9.  Diosgenin stimulation of fecal cholesterol excretion in mice is not NPC1L1 dependent.

Authors:  Ryan E Temel; J Mark Brown; Yinyan Ma; Weiqing Tang; Lawrence L Rudel; Yiannis A Ioannou; Joanna P Davies; Liqing Yu
Journal:  J Lipid Res       Date:  2009-01-13       Impact factor: 5.922

10.  The lipid droplet-associated protein perilipin 3 facilitates hepatitis C virus-driven hepatic steatosis.

Authors:  Daniel Ferguson; Jun Zhang; Matthew A Davis; Robert N Helsley; Lise-Lotte Vedin; Richard G Lee; Rosanne M Crooke; Mark J Graham; Daniela S Allende; Paolo Parini; J Mark Brown
Journal:  J Lipid Res       Date:  2016-12-10       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.